KeyCorp Reaffirms Overweight Rating for Salesforce.com (NYSE:CRM)

KeyCorp reiterated their overweight rating on shares of Salesforce.com (NYSE:CRM) in a research note published on Wednesday, November 22nd, The Fly reports. The firm currently has a $124.00 target price on the CRM provider’s stock, up from their previous target price of $108.00.

CRM has been the subject of a number of other reports. Zacks Investment Research raised Salesforce.com from a hold rating to a buy rating and set a $102.00 price target for the company in a research note on Monday, August 21st. Credit Suisse Group assumed coverage on Salesforce.com in a research note on Tuesday, August 1st. They set an outperform rating and a $110.00 price objective for the company. Wells Fargo & Company reissued a buy rating and set a $100.00 price objective on shares of Salesforce.com in a research note on Thursday, August 24th. BNP Paribas reissued a buy rating and set a $95.00 price objective on shares of Salesforce.com in a research note on Friday, August 25th. Finally, JMP Securities reaffirmed a buy rating and issued a $95.00 target price on shares of Salesforce.com in a research report on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and forty-four have issued a buy rating to the company. Salesforce.com has an average rating of Buy and a consensus price target of $112.48.

Shares of Salesforce.com (NYSE:CRM) traded up $1.15 during trading on Wednesday, hitting $104.07. The stock had a trading volume of 3,898,355 shares, compared to its average volume of 4,455,816. Salesforce.com has a fifty-two week low of $68.23 and a fifty-two week high of $109.19. The company has a debt-to-equity ratio of 0.08, a current ratio of 0.82 and a quick ratio of 0.82. The firm has a market cap of $75,170.00, a PE ratio of 314.66, a price-to-earnings-growth ratio of 9.46 and a beta of 1.24.

Salesforce.com (NYSE:CRM) last posted its earnings results on Tuesday, November 21st. The CRM provider reported $0.39 EPS for the quarter, beating the consensus estimate of $0.37 by $0.02. The firm had revenue of $2.68 billion for the quarter, compared to analysts’ expectations of $2.65 billion. Salesforce.com had a return on equity of 2.81% and a net margin of 0.09%. The firm’s revenue was up 25.0% compared to the same quarter last year. During the same period last year, the firm earned $0.24 EPS. research analysts forecast that Salesforce.com will post 0.43 EPS for the current year.

In other Salesforce.com news, CAO Joe Allanson sold 622 shares of the company’s stock in a transaction on Friday, November 24th. The shares were sold at an average price of $106.77, for a total transaction of $66,410.94. Following the completion of the sale, the chief accounting officer now owns 29,062 shares in the company, valued at approximately $3,102,949.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Vice Chairman Keith Block sold 7,641 shares of the company’s stock in a transaction on Tuesday, September 19th. The shares were sold at an average price of $95.85, for a total transaction of $732,389.85. Following the sale, the insider now owns 14,718 shares of the company’s stock, valued at approximately $1,410,720.30. The disclosure for this sale can be found here. Insiders sold a total of 670,072 shares of company stock valued at $68,439,414 in the last 90 days. 6.20% of the stock is currently owned by corporate insiders.

Hedge funds have recently made changes to their positions in the company. Synovus Financial Corp grew its holdings in shares of Salesforce.com by 10.7% in the 2nd quarter. Synovus Financial Corp now owns 22,247 shares of the CRM provider’s stock valued at $1,927,000 after buying an additional 2,144 shares during the period. Dai Ichi Life Insurance Company Ltd boosted its stake in Salesforce.com by 142.5% in the 2nd quarter. Dai Ichi Life Insurance Company Ltd now owns 124,707 shares of the CRM provider’s stock worth $10,800,000 after purchasing an additional 73,271 shares during the period. Rosenblum Silverman Sutton S F Inc. CA boosted its stake in Salesforce.com by 15.6% in the 2nd quarter. Rosenblum Silverman Sutton S F Inc. CA now owns 60,612 shares of the CRM provider’s stock worth $5,249,000 after purchasing an additional 8,181 shares during the period. Prudential Financial Inc. boosted its stake in Salesforce.com by 1.4% in the 2nd quarter. Prudential Financial Inc. now owns 911,249 shares of the CRM provider’s stock worth $78,914,000 after purchasing an additional 12,516 shares during the period. Finally, Summit Global Investments boosted its stake in Salesforce.com by 85.3% in the 2nd quarter. Summit Global Investments now owns 23,394 shares of the CRM provider’s stock worth $2,026,000 after purchasing an additional 10,768 shares during the period. 85.75% of the stock is owned by institutional investors.

WARNING: This piece was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2017/12/07/keycorp-reaffirms-overweight-rating-for-salesforce-com-inc-crm.html.

Salesforce.com Company Profile

Salesforce.com, inc. is a provider of enterprise software, delivered through the cloud, with a focus on customer relationship management (CRM). The Company focuses on cloud, mobile, social, Internet of Things (IoT) and artificial intelligence technologies. The Company’s service offerings are configured and integrated with other platforms and enterprise applications.

The Fly

Analyst Recommendations for Salesforce.com (NYSE:CRM)

Receive News & Ratings for Salesforce.com Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Salesforce.com Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply